On 25 May 2025, after three years of negotiation under the auspices of the World Health Organization (WHO), the Pandemic Agreement was adopted. In reality, the vote was a provisional outcome of an incomplete treaty which postponed decisions on a number of contentious articles, including the required financing, sharing of intellectual property and biological samples, and transfer of manufacturing know-how and pharmaceutical products on concessional terms, to follow-up negotiations.